arly half of them die. Yet
this is an entirely preventable disease," said Peer Schatz, CEO of QIAGEN
(Nasdaq:
QGEN; Frankfurt, Prime Standard: QIA), the company that developed
the digene(R) HPV Test, which will be used in the SSA's program and is the
only such test approved by the U.S. Food and Drug Administration. It also is
available in many other countries of the world. "The Mexican government is
taking a leadership role in Latin America, and the world, and QIAGEN is
committed to joining with the SSA to assure that our advanced screening
technology is accessible to women everywhere, no matter what their income
level or social class."
In the majority of women, the virus goes away or is suppressed by the
body before it causes any problems. However, in others, the infection lingers
and can cause abnormal cells to form. While the traditional Pap smear is
usually able to find abnormal cells, it sometimes misses them. A study
published in the Journal of the National Cancer Institute found that about
one-third of invasive cervical cancers developed in women whose smears had
appeared normal. In contrast, HPV testing detects the presence of the virus
itself. In the national norms for cervical cancer prevention, which were
updated in 2007, physicians are advised that they can supplement the Pap with
HPV testing in women 25-65 for additional protection. If abnormal cells are
diagnosed early, they can be removed before they develop into cervical cancer.
It is estimated that 6 million women a year will be eligible for HPV
testing through the Mexican public health system once the screening program
is national. An additional 1 million women can access the test using private
insurance.
About HPV and cervical cancer (theHPVtest.com and theHPVtest.com/espanol)
Worldwide, cervical cancer affects nearly 500,000
'/>"/>
SOURCE Qiagen N V Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related biology technology :1.
Neogen Forms Mexican Subsidiary2.
ICx Awarded $1.5 M Contract by Department of Homeland Security for Development of Next Generation Bio Aerosol Systems3.
Sanofi-aventis Announces Settlement of Average Wholesale Price Civil Suits With the U.S. Department of Justice Relating to Anzemet(R)4.
CHS Receives Prestigious Honor from Department of Defense5.
GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program6.
HHS Issues First Department-Wide Report on Personalized Health Care7.
PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services8.
Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key9.
UPDATE: Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key10.
BIO-key(R) Awarded Contract to Deploy Incident Reporting System for Littleton, CO Police Department11.
Detroit Department of Health and Wellness Promotion Selects Netsmart Technologies Public Health Software